White House goes back to well on COVID funding as critics question plans

Published



Political battles over the response to COVID-19 are here to stay, the latest example being a partisan fight over how to pay for additional relief funds that will go toward testing, vaccines, treatments, and research and development.

The White House is asking Congress to approve $15.6 billion in new COVID-19 spending, making the case in a March 3 document titled “Meeting Urgent Needs,” and the Biden administration and congressional Democrats have been making the case since.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.